Three Pathogenic Axes Underlying Prurigo Nodularis and Its Systemic Comorbidities
- 1Department of Dermatology, University of Occupational and Environmental Health, 1-1, Iseigaoka, Yahatanishi-Ku, Kitakyushu 807-8555, Japan
- 2Department of Dermatology, Hanoi Medical University, Hanoi 10000, Vietnam
- 3Department of Plastic Aesthetic Surgery and Rehabilitation, National Hospital of Dermatology and Venereology, Hanoi 10000, Vietnam
Abstract
Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized by severe pruritus and hyperkeratotic nodules. Growing epidemiological evidence indicates that PN is associated with a broad spectrum of systemic comorbidities, including cardiovascular, thyroid, renal, hepatic, psychiatric, pulmonary, and skeletal disorders. However, the biological mechanisms underlying these associations remain incompletely understood. In this review, we propose a framework comprising three interconnected pathogenic axes underlying PN: immune dysregulation, neural dysregulation, and tissue remodeling. Type 2 and type 17 inflammatory pathways, neuroimmune interactions, and fibroblast-mediated extracellular matrix remodeling contribute to PN pathogenesis, while selected immune-inflammatory and remodeling pathways may also have extracutaneous relevance. In particular, IL-4, IL-13, IL-17, and IL-31 may participate in inflammatory and remodeling processes across multiple organs. Although current evidence does not establish a causal relationship between PN and its systemic comorbidities, integration of epidemiological and mechanistic findings supports a broader view of PN beyond the skin. This three-axis framework may provide a conceptual basis for future studies aimed at identifying biomarkers, clarifying systemic disease risk, and defining the clinical relevance of shared pathogenic pathways in PN-associated comorbidities.
Related
- The Role of Neutrophil Extracellular Traps (NETosis) in Systemic Lupus Erythematosus: Molecular Mechanisms, Pathogenic Roles, Diagnostic Biomarkers, and Emerging Therapeutic Strategies
- One ring to rule: Cytokinesis in model and pathogenic fungi
- Characteristics of predicated pathogenic missense variants in human genes for Mendelian disorders
- Burden of pathogenic variants in genes associated with medically actionable disease in the Slovenian population
- Dynamic three-dimensional chromatin remodeling in lung disease: mechanistic principles, pathogenic regulatory networks, and translational challenges
BibTeX
@article{hara2026three,
title = {{Three Pathogenic Axes Underlying Prurigo Nodularis and Its Systemic Comorbidities}},
author = {Reiko Hara and Tan Manh Nguyen and Natsuko Saito-Sasaki and Yu Sawada},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272210264},
url = {https://www.mdpi.com/1422-0067/27/22/10264},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Three Pathogenic Axes Underlying Prurigo Nodularis and Its Systemic Comorbidities
AU - Reiko Hara
AU - Tan Manh Nguyen
AU - Natsuko Saito-Sasaki
AU - Yu Sawada
PY - 2026
DA - 2026/11/16
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272210264
UR - https://www.mdpi.com/1422-0067/27/22/10264
AB - Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized by severe pruritus and hyperkeratotic nodules. Growing epidemiological evidence indicates that PN is associated with a broad spectrum of systemic comorbidities, including cardiovascular, thyroid, renal, hepatic, psychiatric, pulmonary, and skeletal disorders. However, the biological mechanisms underlying these associations remain incompletely understood. In this review, we propose a framework comprising three interconnected pathogenic axes underlying PN: immune dysregulation, neural dysregulation, and tissue remodeling. Type 2 and type 17 inflammatory pathways, neuroimmune interactions, and fibroblast-mediated extracellular matrix remodeling contribute to PN pathogenesis, while selected immune-inflammatory and remodeling pathways may also have extracutaneous relevance. In particular, IL-4, IL-13, IL-17, and IL-31 may participate in inflammatory and remodeling processes across multiple organs. Although current evidence does not establish a causal relationship between PN and its systemic comorbidities, integration of epidemiological and mechanistic findings supports a broader view of PN beyond the skin. This three-axis framework may provide a conceptual basis for future studies aimed at identifying biomarkers, clarifying systemic disease risk, and defining the clinical relevance of shared pathogenic pathways in PN-associated comorbidities.
SN - 1422-0067
ER -